www.fiercebiotech.com Open in urlscan Pro
104.18.0.165  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Webinar


CIRCULATING AND LOCAL ANTIBODIES AS NOVEL CANCER BIOMARKERS

Jun 28, 2023 11:00am ET
60 Minutes
Share
share on linkedin
share on twitter
share on facebook
share on email
copy link

Circulating and local antibodies are revolutionizing cancer diagnosis and
treatment.

B cell differentiation and the production of tumour-specific antibodies are
dynamic processes influenced by changing tumour antigen profiles and
microenvironmental signals. By analyzing circulating antibody characteristics
and dynamics, we gain insight into the bi-directional engagement between the
immune system and tumours, and identify novel blood-based biomarkers that can
result in the discovery of novel cancer therapies.

Join us for this this insightful webinar to learn how antibody profiling has
been used to successfully identify novel diagnostic, prognostic, therapeutic,
and predictive biomarkers in melanoma, prostate cancer, breast cancer, ovarian
cancer, and rare cancers, yielding promising results. See how simultaneously
assaying a significant proportion of the systemic tumour antigen-specific
antibody repertoire, a unique snapshot of the tumour can be obtained which
circumvents the influence of inter- and intra- tumour heterogeneity that affect
tissue-based techniques.

Don't miss out on this opportunity to discover the latest advances in cancer
research!


SPEAKERS


JESSICA DA GAMA DUARTE

Research Fellow, Tumour Immunology Laboratory, Tumour Environment and Immunology
Program
Olivia Newton-John Cancer Research Institute

Brief biosketch: Dr Jessica Da Gama Duarte received a PhD in Medical
Biochemistry at the University of Cape Town, South Africa in 2015, where she
developed a novel cancer array. She was then recruited by the Olivia Newton-John
Cancer Research Institute, Australia, which provides a direct link between
research and clinical practice. Her research is focused on the identification of
novel diagnostic, prognostic, and predictive cancer biomarkers, and on
understanding the role of B cells, autoantibodies, and tertiary lymphoid
structures in cancers.


REGISTER HERE!

Already registered? Click here to login.
Date/Time:
Jun 28, 2023 11:00am ET
Duration:
60 Minutes

 * Connect
   
   * The Team
   * Advertise
 * Join Us
   
   * Newsletters
   * Resources
   * RSS Feeds
 * Our Brands
   
   * Fierce Pharma
   * Fierce Biotech
   * Fierce Healthcare
 * Our Events
   
   * Life Sciences Events

©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy


Close

In order to deliver a personalized and enhanced site navigation, we store
information on how you use the site. By continuing to use this site and access
it's features, you are consenting to our use of cookies. For more information,
please see the Questex Privacy Policy.